RN7SL337P

RNA — tumor vs normal
Tumor vs NormalRNABox plot · TCGA cohorts

Across TCGA pan-cancer cohorts, RN7SL337P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RN7SL337P’s most consistent transcriptional readouts.

The strongest signal is observed in prostate adenocarcinoma (PRAD), where RN7SL337P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL337P is over-expressed in tumor.

PRAD and KIRC are the cancer types where RN7SL337P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL337P RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.
LineageGenderStageFold-changepSampling consensus
PRADAllAll+0.053.0132view →
KIRCAllAll+0.036.0042view →
Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RN7SL337P–PRAD

Tumor-vs-normal expression box plot for RN7SL337P RNA in PRAD.

Open the PRAD breakdown →

Exploration